83 related articles for article (PubMed ID: 11409315)
21. Stable and unstable chromosome aberrations measured after occupational exposure to ionizing radiation and ultrasound.
Fucić A; Zeljezić D; Kasuba V; Kopjar N; Rozgaj R; Lasan R; Mijić A; Hitrec V; Lucas JN
Croat Med J; 2007 Jun; 48(3):371-7. PubMed ID: 17589981
[TBL] [Abstract][Full Text] [Related]
22. Complex chromosome aberrations persist in individuals many years after occupational exposure to densely ionizing radiation: an mFISH study.
Hande MP; Azizova TV; Burak LE; Khokhryakov VF; Geard CR; Brenner DJ
Genes Chromosomes Cancer; 2005 Sep; 44(1):1-9. PubMed ID: 15912529
[TBL] [Abstract][Full Text] [Related]
23. Impact of radiation quality on the spectrum of induced chromosome exchange aberrations.
Boei JJ; Vermeulen S; Mullenders LH; Natarajan AT
Int J Radiat Biol; 2001 Aug; 77(8):847-57. PubMed ID: 11571018
[TBL] [Abstract][Full Text] [Related]
24. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
[TBL] [Abstract][Full Text] [Related]
25. [Chromosomal instability parameters in the population affected by nuclear explosions at the Semipalatinsk nuclear test site].
Abil'dinova GZh; Kuleshov NP; Sviatova GS
Genetika; 2003 Aug; 39(8):1123-7. PubMed ID: 14515470
[TBL] [Abstract][Full Text] [Related]
26. Genotoxic effects of radiotherapy and chemotherapy on circulating lymphocytes in patients with Hodgkin's disease.
Bilban-Jakopin C; Bilban M
Mutat Res; 2001 Oct; 497(1-2):81-8. PubMed ID: 11525910
[TBL] [Abstract][Full Text] [Related]
27. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
28. [Preliminary results of thyroid function assessment in children and adolescents with Hodgkin's disease (HD) treated according to PGP-HD-97 protocol].
Moryl-Bujakowska A; Balwierz W; Sztefko K
Przegl Lek; 2004; 61 Suppl 2():81-4. PubMed ID: 15686053
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy and radiotherapy in Hodgkin's lymphoma: joining in or splitting up?
van der Maazen RW; Raemaekers JM
Curr Opin Oncol; 2006 Nov; 18(6):660-6. PubMed ID: 16988591
[TBL] [Abstract][Full Text] [Related]
30. Effect of ionizing radiation on the pteridine metabolic pathway and evaluation of its cytotoxicity in exposed hospital staff.
Engin AB; Ergun MA; Yurtcu E; Kan D; Sahin G
Mutat Res; 2005 Aug; 585(1-2):184-92. PubMed ID: 15998597
[TBL] [Abstract][Full Text] [Related]
31. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
32. Analysis of chromosome damage in circulating lymphocytes of radiological workers affected by thyroid nodules.
Scarpato R; Antonelli A; Ballardin M; Cipollini M; Fallahi P; Tomei A; Traino C; Barale R
Mutat Res; 2006 Jul; 606(1-2):21-6. PubMed ID: 16713331
[TBL] [Abstract][Full Text] [Related]
33. [The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group].
Balwierz W; Moryl-Bujakowska A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Sopyło B; Stańczak E; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Odój T; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Kołtan S; Krawczuk-Rybak M; Muszyńska-Rosłan K; Zuj G;
Przegl Lek; 2006; 63(1):25-8. PubMed ID: 16892895
[TBL] [Abstract][Full Text] [Related]
34. Incidence of chromosomal aberrations and micronuclei in cave tour guides.
Bilban M; Bilban-Jakopin C; Vrhovec S
Neoplasma; 2001; 48(4):278-84. PubMed ID: 11712679
[TBL] [Abstract][Full Text] [Related]
35. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
Donaldson SS; Link MP; Weinstein HJ; Rai SN; Brain S; Billett AL; Hurwitz CA; Krasin M; Kun LE; Marcus KC; Tarbell NJ; Young JA; Hudson MM
J Clin Oncol; 2007 Jan; 25(3):332-7. PubMed ID: 17235049
[TBL] [Abstract][Full Text] [Related]
36. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
38. Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.
Niehues T; Schellong G; Dörffel W; Bucsky P; Mann G; Körholz D; Göbel U
Klin Padiatr; 2003; 215(6):315-20. PubMed ID: 14677095
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the genotoxic effects of chronic low-dose ionizing radiation exposure on nuclear medicine workers.
Sahin A; Tatar A; Oztas S; Seven B; Varoglu E; Yesilyurt A; Ayan AK
Nucl Med Biol; 2009 Jul; 36(5):575-8. PubMed ID: 19520299
[TBL] [Abstract][Full Text] [Related]
40. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
